ArticleTrials2021

Protecting clinical trials in cystic fibrosis during the SARS-CoV-2 pandemic: risks and mitigation measures.

Silke van Koningsbruggen-Rietschel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.